A retrospective analysis of 25 infants and young children with anogenital warts was performed by chart review and telephone interview. Fifteen of 17 patients treated with podofilox 0.5% gel and 6 of 8 patients treated with imiquimod 5% cream improved or cleared with therapy. Only one patient stopped treatment because of irritation. Our experience suggests that these agents can be used safely and effectively in young children. Controlled prospective studies should be undertaken to further evaluate the use of podofilox and imiquimod in the treatment of symptomatic anogenital warts in children.

No abstract

We investigated whether or not individuals who are allergic to formaldehyde and various formaldehyde-releasing preservatives must avoid exposure to another closely related formaldehyde-releasing allergen to which they were patch test negative. We found that in over 86% of cases a broad restriction of all formaldehyde-releasing preservatives was not required if the patch test was negative. Usually the patch test is predictive of which materials need to be totally avoided. Restriction of exposure to all of the formaldehyde-releasing preservatives may be overly restrictive.

No abstract